---
title: "ALK: Obtained the drug registration certificate for Levofloxacin Tablets"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/261747243.md"
description: "ALK announced that it recently received the \"Drug Registration Certificate\" for Levofloxacin Tablets issued by the National Medical Products Administration. Levofloxacin Tablets are a third-generation fluoroquinolone antibacterial drug, characterized by a broad antibacterial spectrum and strong antibacterial effects, used to treat mild, moderate, and severe infections in adults caused by specified sensitive strains. The company received the notice of acceptance for the drug marketing authorization application in April 2024 and has recently been approved"
datetime: "2025-10-19T07:34:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261747243.md)
  - [en](https://longbridge.com/en/news/261747243.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261747243.md)
generator: "portal-rs"
---

# ALK: Obtained the drug registration certificate for Levofloxacin Tablets

ALK announced that it recently received the "Drug Registration Certificate" for Levofloxacin Tablets issued by the National Medical Products Administration. Levofloxacin Tablets are a third-generation fluoroquinolone antibacterial drug, characterized by a broad antibacterial spectrum and strong antibacterial effects, used to treat mild, moderate, and severe infections in adults caused by specified sensitive strains. The company received the notice of acceptance for the drug marketing authorization application in April 2024 and has recently been approved

### Related Stocks

- [002940.CN](https://longbridge.com/en/quote/002940.CN.md)

## Related News & Research

- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [REG - Aberdeen Asian Inc - Director/PDMR Shareholding](https://longbridge.com/en/news/296505605.md)
- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**